Brent Eberhard
Pediatrics · Layton, UTNPI 1679559629
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.6% of the total across 125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $623 and has fallen 78.3% since, to $135 in 2025. Among pediatrics clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 125 payments — averaging $18.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$449
- Pfizer$373
- Ironshore Pharmaceuticals Inc.$183
- Comsort, Inc$150
- Tris Pharma Inc$150
- GSK$139
- plus $889 from 19 others
Across 187 payments — averaging $2751.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$208K
- Merck$203K
- Pfizer$95K
- AstraZeneca$9K
What the payments were for
- Consulting fees$1506%
- Food & beverage$2,18394%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 11 | $449 |
| Pfizer | 33 | $373 |
| Ironshore Pharmaceuticals Inc. | 10 | $183 |
| Comsort, Inc | 1 | $150 |
| Tris Pharma Inc | 9 | $150 |
| GSK | 10 | $139 |
| Sanofi Pasteur Inc. | 6 | $110 |
| Cranial Technologies, Inc | 5 | $87 |
| Genentech USA, Inc. | 5 | $80 |
| Sanofi-aventis U.S. LLC | 4 | $78 |
| Neurelis, Inc. | 5 | $75 |
| Sobi, Inc | 4 | $71 |
| Merck | 4 | $62 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
| AstraZeneca | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Adlon Therapeutics L.p. | 2 | $33 |
| Shire North American Group Inc | 2 | $30 |
| Ascendis Pharma Endocrinology Inc | 1 | $27 |
| Phadia US Inc. | 1 | $24 |
| Corium, LLC | 1 | $22 |
| AbbVie | 1 | $20 |
| Seqirus USA Inc | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,333 in reported general payments places this provider in the 90th percentile of 439 pediatrics providers in Utah.
Other pediatrics in Layton
- Mari LuceLayton$289K
- Michael HussemanLayton$4K
- Noel NyeLayton$3K
- Nathan ForbushLayton$3K
- Ryan EvansLayton$3K
- Jason HoaglandLayton$2K
- Bryan EllertsonLayton$2K
- Robert HokiLayton$2K
- Colton RagsdaleLayton$2K
- David NuttallAmerican Fork$307K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.